Arvinas, Inc. (ARVN) vs Puma Biotechnology, Inc. (PBYI)
Arvinas, Inc. and Puma Biotechnology, Inc. are both Biotechnology companies. Arvinas, Inc. and Puma Biotechnology, Inc. are of similar size ($509.4M and $506.9M). Puma Biotechnology, Inc. trades at the lower P/E: 18.1× against 58.3×. Puma Biotechnology, Inc. grew revenue faster over the last twelve months: −2.86% against −15.1%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 2.94%) and the higher return on invested capital (42.6% vs 0.00%). Across the 20 metrics below, Puma Biotechnology, Inc. leads on 12 and Arvinas, Inc. on 8.
Valuation
Profitability
| Metric | ARVN | PBYI | Biotechnology median |
|---|---|---|---|
| Gross margin | 97.16% | 74.83% | 65.16% |
| Operating margin | (5.72%) | 13.16% | 0.00% |
| Net margin | 2.94% | 11.55% | 0.00% |
| Free cash flow margin | (65.93%) | 17.79% | 0.00% |
| Return on equity | 1.59% | 21.97% | (57.72%) |
| Return on assets | 1.17% | 13.78% | (49.22%) |
| Return on invested capital | 0.00% | 42.61% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack